Clinical Trials Logo

Craniocerebral Trauma clinical trials

View clinical trials related to Craniocerebral Trauma.

Filter by:
  • Active, not recruiting  
  • Page 1 ·  Next »

NCT ID: NCT05629169 Active, not recruiting - Clinical trials for Traumatic Brain Injury

Video Review of the Frequency and Assessment of Head Impacts During the FIFA World Cup 2022TM

Start date: November 20, 2022
Phase:
Study type: Observational

This is an exploratory observational study. Broadcasted video footage is used to review all head impacts during all 64 matches in the football tournament. All head impacts are registered, and simple descriptive statistics are used to create overviews of the head impact characteristics, including video signs of potential concussion, observed contact, location of the head impact, presence and timing of medical assessment, whether there was foul play and sanction, and if the player was substituted.

NCT ID: NCT05490576 Active, not recruiting - Clinical trials for Cognitive Impairment

Tau And Connectomics In TES Study

TACIT
Start date: February 3, 2023
Phase: Phase 1
Study type: Interventional

This pilot study aims to assess if participants that meet the criteria for a TES diagnosis have a specific tau deposition profile on PET scanning using the PET tau binding ligand - [18F] PI-2620. It is hoped this study will highlight potential diagnostic tests of TES diagnosis, the in-life correlate of CTE.

NCT ID: NCT05400551 Active, not recruiting - Concussion, Brain Clinical Trials

Craneofacial Injuries in Rink Hockey Athletes

Start date: September 1, 2022
Phase:
Study type: Observational

To collect the number of injuries that affect the face and head in rink hockey athletes prospectively during a regular season.

NCT ID: NCT04313712 Active, not recruiting - Head Injury Trauma Clinical Trials

Pre-post Evaluation of the Safety and Efficacy of Ibogaine-Magnesium Therapy in Veterans With Repeated Blast Exposure

Start date: November 15, 2021
Phase:
Study type: Observational

A Pre-post Study Evaluating the Safety and Efficacy of Ibogaine-Magnesium Therapy in Veterans with Sequelae of Repeated Blast Exposure.

NCT ID: NCT03905031 Active, not recruiting - Clinical trials for Traumatic Brain Injury

Defining the Operating Characteristics of NIRS in the Diagnosis of Pediatric Traumatic Intracranial Hemorrhage

Start date: April 15, 2019
Phase: N/A
Study type: Interventional

In this study, investigators look at a different type of technology that might help to avoid having to perform CT scans in certain patients suspected of having a head injury. Near-infrared spectroscopy (NIRS) uses a specific light wavelength to determine if there is bleeding into the head as a result of trauma. Investigators will study NIRS, using a device called the Infrascanner model 2000, to determine if it is as good at detecting bleeding in the head as CT scan, which is the current gold standard. Investigators will try to determine if NIRS can rule in or rule out bleeding into the head, and perhaps this can help to avoid subjecting these youth to the potentially harmful effects of radiation. Investigators will also study how easy it is to use NIRS so that it might become a standard part of the workup for children with suspected head injury.

NCT ID: NCT03608722 Active, not recruiting - Dementia Clinical Trials

Video Games to Track Cognitive Health

Start date: November 2015
Phase: N/A
Study type: Interventional

The purpose of this study is to assess cognitive function using a rapid, portable, computerized neurocognitive testing device in a wide variety of clinical settings.

NCT ID: NCT03441867 Active, not recruiting - Epilepsy Clinical Trials

Neuroimaging Biomarker for Seizures

NIBMSZS
Start date: September 15, 2017
Phase: N/A
Study type: Interventional

This multi-site study will examine patients with epilepsy (ES) following head injury [i.e., posttraumatic epilepsy (PTE)] and posttraumatic psychogenic Non-epileptic seizures (PNES) and will compare them to patients with traumatic brain injury (TBI) who do not have seizures using functional neuroimaging.

NCT ID: NCT03181373 Active, not recruiting - Clinical trials for Brain-damaged Patients

IRM Cognition in Patients With Head Trauma

Start date: September 26, 2014
Phase: N/A
Study type: Observational

Longitudinal descriptive study of a cohort of twenty brain-damaged patients for a two years period.

NCT ID: NCT03052114 Active, not recruiting - Stroke Clinical Trials

Electrical Impedance Tomography of Stroke and Brain Injury

Start date: October 2015
Phase:
Study type: Observational

The purpose of this study is to determine if Electrical Impedance Tomography (EIT) can produce reproducible and accurate images in people with stroke or head injury compared to existing standards such as MRI, CT. Electrical Impedance Tomography is a relatively new medical imaging method, which has the potential to provide novel images of brain function. It is fast, portable, safe and inexpensive, but currently has a relatively poor spatial resolution. It produces images of the internal electrical impedance of a subject with stroke or head injury using rings of ECG like electrodes on the skin. EIT recording will take place as early as possible, usually within 24 hours of admission. Following completion of the recording, the EIT images will subsequently be analysed and compared to other imaging data for accuracy.

NCT ID: NCT00196131 Active, not recruiting - Clinical trials for Subarachnoid Hemorrhage

Problems With Morphine Use in Patients With a Severe Brain Injury

Start date: January 2005
Phase: Phase 1/Phase 2
Study type: Interventional

Hypothesis: During severe brain trauma (injury, surgery) the ensuing inflammatory response in the central nervous system (CNS) results in a decrease in the expression of the transporter protein p-glycoprotein (PGP) in the blood brain barrier. This loss results in the penetration into the brain of certain drugs that are normally excluded by the transporter protein. In this study the working hypothesis is that the agitation observed in patients with CNS trauma treated with morphine is related to the inflammation evoked loss of PGP in the blood brain barrier and the accumulation of the morphine metabolite 3-morphine glucuronide.